Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.89
-0.29 (-2.38%)
At close: Dec 4, 2025, 4:00 PM EST
11.81
-0.13 (-1.09%)
Pre-market: Dec 5, 2025, 4:38 AM EST
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $3.74 billion as of December 5, 2025. Its market cap has increased by 44.82% in one year.
Market Cap
3.74B
Enterprise Value
6.24B
1-Year Change
44.82%
Ranking
Category
Stock Price
$11.89
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $3.74B, an increase of 96.04%. That is a compound annual growth rate of 9.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.75B | 52.96% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | 674.66M | 4.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |